Eric Desrosiers Email & Phone Number

Ottawa, On, Ca

Ottawa, Ontario, Ca

IRAP's mission is to accelerate the growth of small and medium-sized businesses by providing them with a comprehensive suite of innovation services and funding. I specialise in Life Sciences.

Northern Therapeutics Inc. is a private Canadian biopharmaceutical company committed to the discovery and development of novel cell and gene therapies to extend and enhance the quality of life for people suffering from chronic life-threatening pulmonary disorders as well as acute illness, in the absence of toxicity and major side effects.

New World Laboratories (NWL) is a research think-tank with an out-of-the-box approach to developing new therapeutic platforms through Regenerative Medicine R&D. Lead technologies, including drugs, stem cells and biomaterials, have been developed and patented over the past 10+ years. I was responsible for managing the operational aspects, such as project planning, management of resources, regulatory affairs and GMP manufacturing.

Warsaw, Indiana, Us

Zimmer Biomet is a global leader in musculoskeletal healthcare. It offers innovative orthopedic medical devices and joint replacement products in more than 100 countries. I managed the regulatory filings for their ROSA Knee System, Robotic assisted total knee implant surgery.

Retnia develops non-invasive ocular oximetry tools to researchers and eye-care professionals. Retnia's innovative platform was designed to measure oxygen saturation in the eye fundus to help improve patient outcomes and reduce health care costs.

Laval, Quebec, Ca

Klox is a biopharma developing a biophotonic platform technology for Dentistry, Dermatology, Orthopaedics and Tissue Repair. I was responsible for strategic pipeline growth, product and process development and technology transfer, in compliance with GMP and medical devices regulatory requirements. Headed Design control for 4 products (sterile gels and electronic).

Toulouse, Occitanie, Fr

Pierre-Fabre Medicament Production (API): Large French pharmaceutical, with sales in 40+ countries. Quality oversight of 2 production sites specialized in the compounding, filling and lyophilisation of injectable cytotoxic drugs. As consultant, defined and implemented a successful regulatory plan for closing an FDA Warning Letter (closed-out in May 2011).

Validapro expanded its consultation activities to contract biomanufacturing, non-clinical testing and Medical Device development. As VP, I supervised the new Laborium Biopharma division, which offered small scale contract biomanufacturing services (bacterial fermentation, cell culture, USP + DSP, sterile lyo +filling). I also performed consulting services for business development, technical and regulatory support (FDA, Europe, Canada): gap-analysis, audits, training, compliance and Regulatory consultation

Ca

BioSyntech was a Biotech/Medical Device company (now sold to Smith&Nephews) specialised in the R&D and production of thermogel-based sterile liquid medical devices. I joined at start-up and actively contributed to its technological and strategic development. As vice-president, I was responsible for Operations, R&D, aseptic Manufacturing and Quality Control departments.- Sterile manufacturing of liquid injectible medical devices. - R&D in regenerative medicine and therapeutic delivery with chitosan-based thermogels. Invented and developped 3 thermogel-based liquid medical devices.

Toronto, Ontario, Ca

Responsible for scientific direction and R&D of LSR project (Living Skin Replacement). I guided the development of a Skin reconstruction therapy using biodegradable scaffolds, from the initial research up to the transfer of the technology to GMP production for clinical trials.

B.Sc., Biology

Mba, Management Of Bio-Industries

Ph.D., M.Sc.A., Biomedical Engineering

B.Sc., Biochemistry